Skip to main content

candesartan cilexetil and hydrochlorothiazide

NDC 70771-1325 · Zydus Lifesciences Limited

Generic namecandesartan cilexetil and hydrochlorothiazide
Dosage formTABLET
RouteORAL
Active ingredient(s)CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE
Strength16; 12.5 mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

70771-1325-0 — 1000 TABLET in 1 BOTTLE (70771-1325-0)

70771-1325-1 — 100 TABLET in 1 BOTTLE (70771-1325-1)

70771-1325-3 — 30 TABLET in 1 BOTTLE (70771-1325-3)

70771-1325-4 — 10 BLISTER PACK in 1 CARTON (70771-1325-4) / 10 TABLET in 1 BLISTER PACK (70771-1325-2)

70771-1325-9 — 90 TABLET in 1 BOTTLE (70771-1325-9)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70756-315 — telmisartan and hydrochlorothiazide, 70756-316 — telmisartan and hydrochlorothiazide, 70756-317 — telmisartan and hydrochlorothiazide, 70756-812 — Olmesartan Medoxomil and Hydrochlorothiazide, 70756-813 — Olmesartan Medoxomil and Hydrochlorothiazide, 70756-814 — Olmesartan Medoxomil and Hydrochlorothiazide, 70771-1204 — Candesartan cilexetil, 70771-1205 — Candesartan cilexetil, 70771-1206 — Candesartan cilexetil, 70771-1207 — Candesartan cilexetil, 70771-1326 — candesartan cilexetil and hydrochlorothiazide, 70771-1327 — candesartan cilexetil and hydrochlorothiazide, 70771-1361 — triamterene and hydrochlorothiazide, 70771-1362 — triamterene and hydrochlorothiazide, 70771-1474 — Triamterene and Hydrochlorothiazide, 70771-1485 — valsartan and hydrochlorothiazide, 70771-1486 — valsartan and hydrochlorothiazide, 70771-1487 — valsartan and hydrochlorothiazide, 70771-1488 — valsartan and hydrochlorothiazide, 70771-1489 — valsartan and hydrochlorothiazide, +890 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.